Hypertonie in der Schwangerschaft und antihypertensive Therapie^[*]

Zusammenfassung

Das Blutdruckverhalten während der Schwangerschaft in normalen Grenzen ist wichtig für die Gesundheit von Mutter und Kind. Sowohl zu hoher als auch zu niedriger Blutdruck der Mutter beeinträchtigt die Entwicklung des Feten. Hypertensive Schwangerschaftserkrankungen mit der potenziellen Entwicklung einer Präeklampsie sind eine häufige Ursache der perinatalen Mortalität und Müttersterblichkeit. Eine engmaschige Blutdruckkontrolle mit den modernsten Messmethoden ist geeignet, eine Risikoentwicklung frühzeitig zu erkennen und die Therapiesteuerung optimal zu gestalten. Für die antihypertensive Medikation kommen nur wenige Substanzen zur Auswahl.

Abstract

Maintenance of blood pressure within normal limits during pregnancy is important for the health of both mother and baby. Not only high maternal blood pressure but also low values have a negative impact on fetal development. Hypertensive diseases in pregnancy with the potential to develop into preeclampsia are a frequent cause of perinatal mortality and maternal deaths. Close blood pressure monitoring comprising modern methods and devices allows early recognition of risk developments and optimal guidance of antihypertensive therapy. Only a few substances are suitable for antihypertensive treatment in pregnancy.

Schlüsselwörter

Hypertonie - Schwangerschaft - Blutdruck - Therapie

Key words

hypertension - pregnancy - blood pressure - therapy

^* Herrn Prof. E. Erdmann anlässlich seines 70. Geburtstages gewidmet.

• Literatur

• 1 Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2014; (2) CD002252
• 2 Al Khaja K, Sequeira RP, Alkhaja AK et al. Drug treatment of hypertension in pregnancy: a critical review of adult guideline recommendations. J Hypertens 2014; 32: 454-463
• 3 AWMF-Register. 015/018-S1-Leitlinie: Diagnostik und Therapie hypertensiver Schwangerschaftserkrankungen. Im Internet: http://www.awmf.org/uploads/tx_szleitlinien/015-018l_S1_Diagnostik_Therapie_hypertensiver_Schwangerschaftserkrankungen_2014-01.pdf Stand: 12/2013
• 4 Brown MA, Davis GK, McHugh D et al. The prevalence and clinical signifcance of nocturnal hypertension in pregnancy. J Hypertens 2001; 19: 1437-1444
• 5 Clapp JF, Seaward BL, Sleamaker RH et al. Maternal physiologic adaptations to early human pregnancy. Am J Obstet Gynecol 1988; 159: 1456-1460
• 6 Collins R, Yusuf S, Peto R. Overview of randomised trials of diuretics in pregnancy. Br Med J (Clin Res Ed) 1985; 290: 17-23
• 7 Dadelszen von P, Ornstein MP, Bull SP et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000; 355: 87-92
• 8 Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892-898
• 9 Friedman EA, Neff RK. Hypertension-hypotension in pregnancy. Correlation with fetal outcome. JAMA 1978; 239: 2249-2251
• 10 Gaillard R, Steegers EA, Hofman A et al. Associations of maternal obesity with blood pressure and the risks of gestational hypertensive disorders. The Generation R Study. J Hypertens 2011; 29: 937-944
• 11 Grunberger W, Leodolter S, Parschalk O. Maternal hypotension: fetal outcome in treated and untreated cases. Gynecologic Obstetric Invest 1979; 10: 32-38
• 12 Haelterman E, Bréart G, Paris-Llado J et al. Effect of uncomplicated chronic hypertension on the risk of small-for-gestational age birth. Am J Epidemiol 1997; 145: 689-695
• 13 Helewa ME, Burrows RF, Smith J et al. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 1997; 157: 715-725
• 14 Homer C, Brown M, Mangos G et al. Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension. J Hypertens 2008; 26: 295-302
• 15 Lenfant C. Working group report on high blood pressure in pregnancy. J Clin Hypertens (Greenwich) 2001; 3: 75-88
• 16 Magee LA, von Dadelszen P, Chan S et al. The Control of Hypertension In Pregnancy Study pilot trial. BJOG 2007; 114: 770 e13–e20
• 17 Magee LA, Pels A, Helewa M et al. Diagnosis, evaluation and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can 2014; 36: 416-438
• 18 Mahendru AA, Everett TR, Wilkinson IB et al. A longitudinal study of maternal cardiovascular function from preconception to the postpartum period. J Hypertens 2014; 32: 849-856
• 19 Margulies M, Voto LS, Fescina R et al. Arterial blood pressure standards during normal pregnancy and their relation with mother-fetus variables. Am J Obstet Gynecol 1987; 156: 1105-1109
• 20 Middeke M, Köhler F, Schweizer T et al. Telemetrische Blutdruck- und Gewichtskontrolle in der Schwangerschaft. Dtsch Med Wochenschr 2007; 132: 437-441
• 21 Middeke M, Schulz EG. Telemetrische Blutdruck- und Gewichtskontrolle in der Schwangerschaft. In: Goss F, Middeke M, Mengden Th, Smetak N, Hrsg. Praktische Telemedizin in Kardiologie und Hypertensiologie. Stuttgart, New York: Thieme; 2009: 161-168
• 22 Rath W. Hypertensive Schwangerschaftserkrankungen. Gynäkologe 1999; 32: 432-442
• 23 Seely EW, Ecker J. Clinical practice. Chronic hypertension in pregnancy. N Engl J Med 2011; 365: 439-446
• 24 Sibai BM, Abdella TN, Anderson GD. Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol 1983; 61: 571-576
• 25 Steer PJ. The definition of pre-eclampsia. Br J Obstet Gynaecol 1999; 106: 753-755
• 26 Steer PJ, Little MP, Kold-Jensen T et al. Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study. BMJ 2004; 329: 1312-1314
• 27 Villamor E, Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet 2006; 368: 1164-1170